We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danaher's (DHR) Subsidiary Envista Closes IPO, Shares Up
Read MoreHide Full Article
Danaher Corporation’s (DHR - Free Report) dental subsidiary, Envista Holdings Corporation, declared that it has successfully closed the initial public offering (IPO) of its common shares, which was announced this June. Envista started trading on the NYSE from Sep 18, 2019.
On Sep 20, shares of Danaher increased 0.49%, closing the trading session at $146.47. Meanwhile, Envista’s share price grew 2.75% to $28.77. Notably, Envista’s shares have gained 2.93% since it started trading on the stock exchange.
Inside the Headlines
As noted, Envista’s offering size amounted to 30,783.2 thousand shares, consisting of 26,768 thousand shares sold to the public at $22.00 per share and 4,015.2 thousand shares bought by the underwriters (exercising fully the option vested on them). The purchase price for the underwriters (after adjusting for underwriting discounts) was less than $22.00 for each share.
Net proceeds (after deduction of commissions and underwriting discounts) were $643.4 million. Envista has awarded the net proceeds to Danaher as part payment for the transfer of its dental assets.
Currently, Danaher holds approximately 80.6% shares in Envista.
About Envista
Envista consists of Danaher Dental segment's three operating businesses — Nobel Biocare Systems, Ormco and KaVo Kerr. These businesses specialize in dental equipment, orthodontics, dental implants and consumables. Some notable brands are Nobel Biocare, Kerr, i-CAT, KaVo, Dexis, Pelton & Crane, Metrex, Ormco, Implant Direct, and Orascoptic.
Envista provides services to dentists (more than one million) across as many as 150 countries. It employs 12,000 people.
Zacks Rank, Earnings Estimates and Price Performance
With a market capitalization of approximately $105.1 billion, Danaher currently carries a Zacks Rank #2 (Buy). Over the past 60 days, the Zacks Consensus Estimate for its 2019 earnings remained stable at $4.79, while increased 2.4% to $5.59 for 2020.
In the past three months, shares of the company have gained 3.1% against the industry’s 1.7% decline.
Other Stocks to Consider
Three other top-ranked stocks in the same industry are Federal Signal Corporation (FSS - Free Report) , Griffon Corporation((GFF - Free Report) ) and United Technologies Corporation . While Federal Signal and Griffon currently sport a Zacks Rank #1 (Strong Buy), United Technologies carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, these companies witnessed an upward revision in the current year's earnings estimate. In the last reported quarter, Federal Signal, Griffon and United Technologies delivered a positive earnings surprise of 19.57%, 10.71% and 7.84%, respectively.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
Danaher's (DHR) Subsidiary Envista Closes IPO, Shares Up
Danaher Corporation’s (DHR - Free Report) dental subsidiary, Envista Holdings Corporation, declared that it has successfully closed the initial public offering (IPO) of its common shares, which was announced this June. Envista started trading on the NYSE from Sep 18, 2019.
On Sep 20, shares of Danaher increased 0.49%, closing the trading session at $146.47. Meanwhile, Envista’s share price grew 2.75% to $28.77. Notably, Envista’s shares have gained 2.93% since it started trading on the stock exchange.
Inside the Headlines
As noted, Envista’s offering size amounted to 30,783.2 thousand shares, consisting of 26,768 thousand shares sold to the public at $22.00 per share and 4,015.2 thousand shares bought by the underwriters (exercising fully the option vested on them). The purchase price for the underwriters (after adjusting for underwriting discounts) was less than $22.00 for each share.
Net proceeds (after deduction of commissions and underwriting discounts) were $643.4 million. Envista has awarded the net proceeds to Danaher as part payment for the transfer of its dental assets.
Currently, Danaher holds approximately 80.6% shares in Envista.
About Envista
Envista consists of Danaher Dental segment's three operating businesses — Nobel Biocare Systems, Ormco and KaVo Kerr. These businesses specialize in dental equipment, orthodontics, dental implants and consumables. Some notable brands are Nobel Biocare, Kerr, i-CAT, KaVo, Dexis, Pelton & Crane, Metrex, Ormco, Implant Direct, and Orascoptic.
Envista provides services to dentists (more than one million) across as many as 150 countries. It employs 12,000 people.
Zacks Rank, Earnings Estimates and Price Performance
With a market capitalization of approximately $105.1 billion, Danaher currently carries a Zacks Rank #2 (Buy). Over the past 60 days, the Zacks Consensus Estimate for its 2019 earnings remained stable at $4.79, while increased 2.4% to $5.59 for 2020.
Danaher Corporation Price and Consensus
Danaher Corporation price-consensus-chart | Danaher Corporation Quote
In the past three months, shares of the company have gained 3.1% against the industry’s 1.7% decline.
Other Stocks to Consider
Three other top-ranked stocks in the same industry are Federal Signal Corporation (FSS - Free Report) , Griffon Corporation ((GFF - Free Report) ) and United Technologies Corporation . While Federal Signal and Griffon currently sport a Zacks Rank #1 (Strong Buy), United Technologies carries a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Over the past 60 days, these companies witnessed an upward revision in the current year's earnings estimate. In the last reported quarter, Federal Signal, Griffon and United Technologies delivered a positive earnings surprise of 19.57%, 10.71% and 7.84%, respectively.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>